Target Name: MIR4444-2
NCBI ID: G100846999
Review Report on MIR4444-2 Target / Biomarker Content of Review Report on MIR4444-2 Target / Biomarker
MIR4444-2
Other Name(s): hsa-mir-4444-2 | microRNA 4444-2 | hsa-miR-4444 | MicroRNA 4444-2

MIR4444-2: A Drug Target / Disease Biomarker

MIR4444-2 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the MIR44 family of RNA-protein interactions and is responsible for the regulation of microRNA (miRNA) levels in cells.

MIR4444-2 has been shown to play a critical role in the regulation of cellular processes that are involved in cell growth, differentiation, and survival. It has been shown to interact with numerousmiRNAs, including let-7, a miRNA that has been shown to play a role in cancer progression.

In addition to its role in the regulation of miRNA levels, MIR4444-2 has also been shown to play a critical role in the regulation of cellular signaling pathways. It has been shown to interact with numerous protein kinases, including the serine/thionyl-histidine (S/T) kinase, which is involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and survival.

MIR4444-2 has also been shown to play a critical role in the regulation of cellular immune responses. It has been shown to interact with numerous immune cell types, including T cells and natural killer cells, and to be involved in the regulation of the immune response.

In addition to its role in the regulation of cellular processes, MIR4444-2 has also been shown to play a critical role in the regulation of cellular interactions with the extracellular environment. It has been shown to interact with numerous proteins that are involved in cell-cell and cell-extracellular matrix (ECM) interactions, including the protein known as E-cadherin.

MIR4444-2 has been shown to play a critical role in the regulation of cellular processes that are involved in cell growth, differentiation, and survival. It has been shown to interact with numerousmiRNAs, including let-7, and to play a role in the regulation of cellular signaling pathways, including the regulation of cell growth, differentiation, and survival. It has also been shown to play a critical role in the regulation of cellular immune responses and in the regulation of cellular interactions with the extracellular environment.

MIR4444-2 is also a potential drug target. Studies have shown that MIR4444-2 can be inhibited by small molecules, making it a potential target for drug development. Additionally, MIR4444-2 has been shown to play a critical role in the regulation of cellular processes that are involved in cancer progression, making it a potential target for cancer treatment.

In conclusion, MIR4444-2 is a protein that has been shown to play a critical role in the regulation of cellular processes that are involved in cell growth, differentiation, and survival. It is a potential drug target and has been shown to interact with numerousmiRNAs and to play a role in the regulation of cellular signaling pathways, immune responses, and cell-cell and cell-extracellular matrix interactions. Further research is needed to fully understand the role of MIR4444-2 in the regulation of cellular processes and to develop effective treatments for the regulation of cell growth, differentiation, and survival.

Protein Name: MicroRNA 4444-2

The "MIR4444-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4444-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635